AgomAb Therapeutics NV (AGMB)
12.08
+0.67
(+5.87%)
USD |
NASDAQ |
Sep 17, 16:00
12.01
-0.07
(-0.58%)
After-Hours: 20:00
AgomAb Therapeutics Market Cap : 594.92M for Sept. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 17, 2026 | 594.92M |
| September 16, 2026 | 561.92M |
| September 15, 2026 | 598.86M |
| September 14, 2026 | 604.77M |
| September 11, 2026 | 643.18M |
| September 10, 2026 | 686.52M |
| September 09, 2026 | 736.75M |
| September 08, 2026 | 734.29M |
| September 04, 2026 | 777.13M |
| September 03, 2026 | 730.35M |
| September 02, 2026 | 672.73M |
| September 01, 2026 | 666.82M |
| August 31, 2026 | 648.60M |
| August 28, 2026 | 648.60M |
| August 27, 2026 | 681.59M |
| August 26, 2026 | 703.26M |
| August 25, 2026 | 690.46M |
| August 24, 2026 | 631.36M |
| August 21, 2026 | 652.54M |
| August 20, 2026 | 661.40M |
| August 19, 2026 | 677.16M |
| August 18, 2026 | 676.18M |
| August 17, 2026 | 673.71M |
| August 14, 2026 | 651.06M |
| August 13, 2026 | 686.76M |
| Date | Value |
|---|---|
| August 12, 2026 | 694.89M |
| August 11, 2026 | 731.33M |
| August 10, 2026 | 738.72M |
| August 07, 2026 | 714.10M |
| August 06, 2026 | 664.85M |
| August 05, 2026 | 705.23M |
| August 04, 2026 | 717.89M |
| August 03, 2026 | 658.92M |
| July 31, 2026 | 627.24M |
| July 30, 2026 | 621.64M |
| July 29, 2026 | 604.34M |
| July 28, 2026 | 611.16M |
| July 27, 2026 | 609.70M |
| July 24, 2026 | 609.70M |
| July 23, 2026 | 632.12M |
| July 22, 2026 | 565.35M |
| July 21, 2026 | 567.30M |
| July 20, 2026 | 583.87M |
| July 17, 2026 | 586.79M |
| July 16, 2026 | 600.44M |
| July 15, 2026 | 615.55M |
| July 14, 2026 | 586.79M |
| July 13, 2026 | 599.95M |
| July 10, 2026 | 637.48M |
| July 09, 2026 | 635.04M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 15.72M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| GB Sciences, Inc. | 0.0814M |
| Invion Ltd. | 4.030M |
| Arvinas, Inc. | 542.64M |
Market Cap Related Metrics
| Price to Book Value | 3.830 |
| Price | 12.08 |
| Earnings Yield | -5.57% |